Our LinkedIn page is now online: https://www.linkedin.com/company/gatehealth/
Join the page and become a member of our growing network of reseachers!
Novel lipid nanoparticles for mRNA delivery will enhance thermostability, biodegradability and safety and pave the way for new off-the-shelf therapies.
Janssen will produce innovative cell therapies in Belgium. The Tech Lane Science Park in Ghent will be the location of Janssen's first European state-of-the-art facilities for the production of CAR-T therapy. The facilities are being developed in cooperation with Legend Biotech to enable the future production and supply of CAR-T therapy for the treatment of certain types of cancer in Europe.
View the full article on the janssen.com website...
Regenerative medicine is by nature a multi-disciplinary field, in which innovation management is becoming evermore complex. To meet these increasing challenges, Ghent University, University Hospital Ghent, VIB and imec are joining forces. This led to the foundation of GATE, a platform where researchers and clinicians from various disciplines and expertise work together with innovation professionals to develop faster, more efficient and more market-oriented solutions for regenerative medicine gene therapy, (advanced) cell therapy and tissue regeneration.
Our ambition is to cover the complete process from early research to first-in-human clinical trials, realizing the promise of regenerative medicine and advanced therapies.